Jan. 10, 2024 - What is a spurned seller’s recourse when a buyer walks away from a deal in breach of the purchase agreement? In private M&A, the answer is reasonably straightforward: sue the buyer to close the deal or to recover damages. In public M&A, however, the answer is murky at best. The problem arises...
Announcement
Searchlight Pharma Inc. Sells to Apotex Inc.
Davies is acting for the shareholders of Searchlight Pharma Inc. (Searchlight) in connection with the sale of their 100% interest to Apotex Inc. (Apotex).
Searchlight is a private, rapidly-growing Canadian company known for their innovative branded pharmaceuticals with a global reach that executes best-in-class search, acquisition, commercialization and focused development of innovative and unique specialty healthcare products.
Following closing, Apotex will be even better positioned for growth within the specialty branded pharmaceutical market, by adding Searchlight’s diverse portfolio of over 60 products and a full-service branded pharmaceutical platform, as well as Searchlight’s established business development networks in Canada and internationally.
The Davies team that advised on this transaction includes Hillel Rosen, Sébastien Roy, Shayna Goldman, Matthew Hendy, Noah Abitbol and Sergio Rodriguez (M&A); Brian Bloom and Taj Kudhail (Tax); Jim Dinning and Umang Khandelwal (Competition); Max Jarvie, Sumeet Dang and Benoit Archambault (IP/Privacy); Hélène Bussières and Arianna Yoffe (Employment); Marie-Claude Bellemare (Environment); Faiz Lalani (Dispute Resolution).
Related
As the Pandemic Abates, Activists Advance: Shareholder Activism Rebounds in Canada
Oct. 20, 2023 - Canadian shareholder activism continued its post-pandemic resurgence into the first half of 2023. Emerging trends include the “activist swarm,” where multiple—yet uncoordinated—activists converge on a single target with competing demands. Activism has also been on the rise in response to M&A...
